scholarly article | Q13442814 |
P356 | DOI | 10.1093/NDT/GFV375 |
P698 | PubMed publication ID | 26546592 |
P50 | author | Curie Ahn | Q16084618 |
Yu Seun Kim | Q59683475 | ||
Kyu Ha Huh | Q60371912 | ||
Chan-Duck Kim | Q60393289 | ||
Jong Cheol Jeong | Q82369397 | ||
Wookyung Chung | Q88899091 | ||
Han Ro | Q88899094 | ||
Joongyup Lee | Q90041528 | ||
Sung Bae Park | Q90760188 | ||
Jae Berm Park | Q91304167 | ||
Seung-Yeup Han | Q117266928 | ||
P2093 | author name string | Sung Joo Kim | |
Sik Lee | |||
Juhan Lee | |||
Myoung Soo Kim | |||
Jang-Hee Cho | |||
Jaeseok Yang | |||
Borae G Park | |||
Yongjung Park | |||
KNOW-KT Study Group | |||
P2860 | cites work | KNOW-KT (KoreaN cohort study for outcome in patients with kidney transplantation: a 9-year longitudinal cohort study): study rationale and methodology | Q33617623 |
Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients | Q33765684 | ||
Diagnosis and prevention of chronic kidney allograft loss | Q34224452 | ||
Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection | Q35332030 | ||
Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study | Q37097454 | ||
The yin and yang of B cells in graft rejection and tolerance | Q37690953 | ||
Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection | Q38123309 | ||
Pretransplant identification of acute rejection risk following kidney transplantation | Q38151922 | ||
Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety. | Q41527816 | ||
Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss | Q43817587 | ||
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure | Q43918875 | ||
Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies. | Q44260404 | ||
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
Identifying specific causes of kidney allograft loss. | Q45810388 | ||
Complement-binding anti-HLA antibodies and kidney-allograft survival | Q46141053 | ||
Kidney allograft survival after acute rejection, the value of follow-up biopsies | Q46211382 | ||
C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies | Q47571875 | ||
To achieve national self-sufficiency: recent progresses in deceased donation in Korea | Q47728735 | ||
Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies | Q47789001 | ||
Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. | Q48005087 | ||
Antibody-mediated rejection: analyzing the risk, proposing solutions. | Q50463485 | ||
A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. | Q51432032 | ||
The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomes. | Q52876472 | ||
Clinicopathological characteristics and effect of late acute rejection on renal transplant outcomes. | Q53051071 | ||
Anti-angiotensin type 1 receptor antibodies associated with antibody-mediated rejection in patients without preformed HLA-donor-specific antibody. | Q53245556 | ||
Clinical implications of angiotensin II type 1 receptor antibodies in antibody-mediated rejection without detectable donor-specific HLA antibodies after renal transplantation. | Q53536001 | ||
Correlation between HLA-DRB1, HLA-DQB1 polymorphism and autoantibodies against angiotensin AT(1) receptors in Chinese patients with essential hypertension. | Q54373900 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
P304 | page(s) | 1244-1250 | |
P577 | publication date | 2017-07-01 | |
P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
P1476 | title | The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantation | |
P478 | volume | 32 |
Q39105369 | Acute antibody-mediated rejection in kidney transplant recipients |
Q48295872 | Acute kidney transplant rejection mediated by angiotensin II type 1 receptor antibodies in a pediatric hyperimmune patient. |
Q46409439 | Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation |
Q39076219 | Anti-angiotensin II type 1 receptor autoantibodies (AT1R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations. |
Q64956036 | Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients. |
Q37642331 | Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications. |
Q39268286 | Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation |
Q39217968 | Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection |
Q42343473 | Renal association clinical practice guideline in post-operative care in the kidney transplant recipient |
Q42233729 | The Presence of Anti-Angiotensin II Type-1 Receptor Antibodies Adversely Affect Kidney Graft Outcomes. |
Q38877375 | The importance of non-HLA antibodies in transplantation |
Search more.